EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

A Systematic Review of Low-Dose Ketamine for Acute Pain Management in the Emergency Department

Nasser Almulhim, Abdullah Alibrahim, Ali Alajwad, Hanan Alzahrani, Ibrahim Aldandan, Abdulelah Aldabbab, Ahmad Aljaziri, Mayar Ibrahim

Psychoactives · 01.06.2026 · 5 (2) · 15

DOI: 10.3390/psychoactives5020015 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Psychoactives, online erschienen am 01.06.2026. Verfasst von Nasser Almulhim und 7 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute pain is the most common presentation in the emergency department (ED), accounting for approximately 78% of visits and highlighting the need for rapid and effective pain management. Ketamine is a well-established analgesic that can serve as an alternative when opioids are contraindicated. Recently, low-dose ketamine (LDK), also known as sub-dissociative or subanesthetic ketamine, has emerged as a potential option for acute pain control in ED settings; however, evidence regarding its efficacy and safety remains inconsistent. This systematic review aimed to evaluate the effectiveness and safety of LDK for acute pain management in the emergency department. A comprehensive search of SCOPUS, PubMed, and Web of Science was conducted using predefined keywords related to ketamine, acute pain, and emergency care. Peer-reviewed randomized controlled trials (RCTs) published in English between 2015 and 2025 involving adults aged ≥ 18 years were included, and the risk of bias was assessed using the Cochrane Risk of Bias 2 (ROB-2) tool. Sixteen RCTs including 1908 adult patients met the inclusion criteria. The findings were heterogeneous: several studies demonstrated that LDK provided effective pain reduction within 30 min compared with commonly used analgesics such as morphine, ketorolac, and fentanyl, whereas others found no significant superiority, including one placebo-controlled trial. The analgesic effect appeared dose- and administration-dependent, with short intravenous infusions showing better tolerability than bolus dosing. Transient neuropsychiatric adverse effects were reported, but no serious adverse events were identified. Larger multicenter studies are needed to further clarify optimal dosing strategies and confirm the safety profile of LDK in ED pain management.

Zitieren

APA

Almulhim, N., Alibrahim, A., Alajwad, A., Alzahrani, H., Aldandan, I., Aldabbab, A., Aljaziri, A., & Ibrahim, M. (2026). A Systematic Review of Low-Dose Ketamine for Acute Pain Management in the Emergency Department. Psychoactives, 5(2), 15. https://doi.org/10.3390/psychoactives5020015

Vancouver

Almulhim N, Alibrahim A, Alajwad A, Alzahrani H, Aldandan I, Aldabbab A, et al. A Systematic Review of Low-Dose Ketamine for Acute Pain Management in the Emergency Department. Psychoactives. 2026;5(2):15. doi:10.3390/psychoactives5020015

BibTeX
@article{Almulhim2026,
  author = {Almulhim, Nasser and Alibrahim, Abdullah and Alajwad, Ali and Alzahrani, Hanan and Aldandan, Ibrahim and Aldabbab, Abdulelah and Aljaziri, Ahmad and Ibrahim, Mayar},
  title = {A Systematic Review of Low-Dose Ketamine for Acute Pain Management in the Emergency Department},
  journal = {Psychoactives},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {15},
  doi = {10.3390/psychoactives5020015}
}
Kostenlos starten →